Anixa Biosciences
ANIX
57 hedge funds and large institutions have $13.6M invested in Anixa Biosciences in 2024 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 9 closing their positions.
224% more call options, than puts
Call options by funds: $201K | Put options by funds: $62K
22% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 9
11% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 9
0.7% more ownership
Funds ownership: 17.45% → 18.15% (+0.7%)
2% less funds holding
Funds holding: 58 → 57 (-1)
23% less capital invested
Capital invested by funds: $17.6M → $13.6M (-$4.02M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$576K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$255K |
| 3 |
Focus Partners Wealth
Boston,
Massachusetts
|
+$217K |
| 4 |
Jane Street
New York
|
+$89.6K |
| 5 |
KAS
Kestra Advisory Services
Austin,
Texas
|
+$86.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$140K |
| 2 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$129K |
| 3 |
MWM
Mission Wealth Management
Santa Barbara,
California
|
-$124K |
| 4 |
IAIM
International Assets Investment Management
Orlando,
Florida
|
-$83.2K |
| 5 |
LFCM
Long Focus Capital Management
San Juan,
Puerto Rico
|
-$57K |
ANIX Hedge Fund Activity: Q4 2024 in Review
57 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q4 2024, worth a combined $13.6M — down 23% from $17.6M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new ANIX positions and 9 closed out — a net gain of 1 holder — while 11 added to existing stakes and 9 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $576K. The largest seller was Marshall Wace, exiting entirely with an estimated $140K sold.
- 57 institutional investors held Anixa Biosciences (ANIX) as of Q4 2024, down from 58 in Q3 2024.
- Funds reported $13.6M of Anixa Biosciences stock for Q4 2024, down 23% quarter-over-quarter.
- 10 funds opened new Anixa Biosciences positions in Q4 2024 and 9 closed out, a net change of +1 holder.
- The largest Anixa Biosciences buyer in Q4 2024 was Susquehanna International Group, an estimated $576K added.
- The largest Anixa Biosciences seller in Q4 2024 was Marshall Wace, an estimated $140K sold.
Based on aggregated 13F filings for Q4 2024.